Authors:
HUTZELMANN J
OWENS S
SHEDDEN A
ADAMSONS I
VARGAS E
Citation: J. Hutzelmann et al., COMPARISON OF THE SAFETY AND EFFICACY OF THE FIXED COMBINATION OF DORZOLAMIDE TIMOLOL AND THE CONCOMITANT ADMINISTRATION OF DORZOLAMIDE ANDTIMOLOL - A CLINICAL EQUIVALENCE STUDY/, British journal of ophthalmology, 82(11), 1998, pp. 1249-1253
Citation: J. Hutzelmann et al., COMPARISON OF TOLERABILITY AND EFFICACY OF DORZOLAMIDE AND ACETAZOLAMIDE AS ADJUNCTIVE THERAPY TO TIMOLOL, Investigative ophthalmology & visual science, 38(4), 1997, pp. 2611-2611
Citation: I. Adamsons et al., COMPARISON OF SUMMARY MEASURES FOR ANALYZING LONGITUDINAL VISUAL-FIELD DATA, Investigative ophthalmology & visual science, 37(3), 1996, pp. 4331-4331
Authors:
SHEDDEN AH
HUTZELMANN J
LAURENCE JK
SHARMA D
Citation: Ah. Shedden et al., PRESERVATIVE DID NOT INFLUENCE THE OCULAR HYPOTENSIVE EFFECT OF TIMOLOL MALEATE OPHTHALMIC GEL-FORMING SOLUTION (TIMOPTIC-XE(R), TXE), Investigative ophthalmology & visual science, 37(3), 1996, pp. 5055-5055
Authors:
HUTZELMANN J
SNYDER E
TIPPING R
ADAMSONS I
Citation: J. Hutzelmann et al., COMPARISON OF THE IOP LOWERING EFFECT OF 2.0-PERCENT DORZOLAMIDE TID (TRUSOPT) IN PATIENTS WITH LIGHT AND DARK IRIDES, Investigative ophthalmology & visual science, 37(3), 1996, pp. 5062-5062
Authors:
CONNOR J
STRAHLMAN ER
LIPPA EA
TIPPING R
HUTZELMANN J
Citation: J. Connor et al., A PLACEBO-CONTROLLED CLINICAL-TRIAL OF 0.7-PERCENT DORZOLAMIDE (MK-507) AND TIMOLOL, Investigative ophthalmology & visual science, 35(4), 1994, pp. 2177-2177